Polielektrolit-frakcionált porcin VIII. faktor egy esetben való alkalmazásáról gátlótestes haemophiliában.

Translated title of the contribution: Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A

T. Ferencz, J. Skopál, C. Csáki, M. Laczkó, D. Schuler, J. Borsi

Research output: Contribution to journalArticle

Abstract

In approximately 10 to 15 percent of congenital hemophilia A patients circulating antibodies to factor VIII appear in the blood that poses a serious problem in their treatment. A number of methods and preparations are used in the clinical practice to overcome this problem. Authors report their favourable clinical experience with the administration of polyelectrolyte-fractionated porcine factor VIII. concentrate in a hemophiliac child for the first time in Hungary and a brief review of the clinical methods in use in the management of factor VIII. inhibitors.

Translated title of the contributionPoly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A
Original languageHungarian
Pages (from-to)2873-2875
Number of pages3
JournalOrvosi hetilap
Volume134
Issue number52
Publication statusPublished - Dec 26 1993

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A'. Together they form a unique fingerprint.

  • Cite this

    Ferencz, T., Skopál, J., Csáki, C., Laczkó, M., Schuler, D., & Borsi, J. (1993). Polielektrolit-frakcionált porcin VIII. faktor egy esetben való alkalmazásáról gátlótestes haemophiliában. Orvosi hetilap, 134(52), 2873-2875.